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The	 control	 of	 Salmonella	 enterica	 in	 pig	 production	 is	 necessary	 for	 both	 public	 and	 animal	15	
health.	 Vaccination	 is	 one	 control	 measure	 that	 has	 potential	 to	 decrease	 slaughter	 pig	16	
prevalence.	The	study	examined	 the	efficacy	of	a	 licensed	 live	 Salmonella	 Typhimurium	vaccine,	17	
administered	 to	 sows	 on	 eight	 commercial	 farrow-to-finish	 pig	 herds	 experiencing	 clinical	18	
salmonellosis	 or	 high	 prevalence	 of	 Salmonella	 carriage	 associated	 with	 S.	 Typhimurium	 or	 its	19	
monophasic	 variants	 (S.	 1,4,[5],12:i-	 or	 S.	 1,4,12:i-).	 Results	 of	 longitudinal	 Salmonella	 sampling		20	
were	compared	against	eight	similarly	selected	and	studied	control	farms.	One	year	after	the	start	21	
of	 vaccination,	when	all	 finishing	 stock	had	been	born	 to	 vaccinated	 sows,	 clinical	 salmonellosis	22	
resolved	and	both	faecal	shedding	and	environmental	prevalence	of	S.	Typhimurium	substantially	23	
declined	 in	 the	majority	of	 farms.	 	However,	Salmonella	 counts	 in	positive	 faeces	 samples	were	24	
similar	 between	 non-vaccinated	 and	 vaccinated	 herds.	 In	 addition,	 vaccination	 did	 not	 have	 a	25	
measurable	impact	on	piglets’	and	sows’	performance,	including	average	daily	liveweight	gain	for	26	












EFSA,	 2016).	 It	 is	 estimated	 that	 13%	 of	 outbreaks	 are	 associated	 with	 pig	meat	 and	 products	37	
thereof	(EFSA,	2016).	Pork	is	considered,	after	eggs,	the	major	source	of	infection	in	humans	in	the	38	
EU,	 with	 S.	 Typhimurium,	 including	 monophasic	 strains	 (S.1,4,[5],12:i-	 and	 S.	 1,4,12:i-)	 being	39	
frequently	implicated	(Andres	and	Davies,	2015;	Davies	et	al.,	2016).	Nonetheless,	within	the	EU,	40	
there	is	no	mandatory	programme	for	the	control	of	Salmonella	at	pork	primary	production	level.	41	
The	 European	 Commission	 (EC)	 has	 considered	 the	measures	 that	 could	 be	 applied	 in	 order	 to	42	
reduce	the	Salmonella	prevalence	in	pigs	across	the	member	states,	and	it	is	likely	that	successful	43	
control	will	include	effective	pre-harvest	actions	in	breeding	herds	(Andres	and	Davies,	2015).	The	44	
EU	 was	 originally	 expected	 to	 introduce	 regulations	 concerning	 the	 monitoring	 and	 control	 of	45	
Salmonella	in	pigs	after	an	initial	focus	on	the	control	of	Salmonella	in	poultry	and	its	subsequent	46	
reduction,	 although	 proposals	 were	 dropped	 following	 a	 negative	 cost–benefit	 analysis	 (DG	47	
SANCO	 2010).	 However,	 despite	 enhanced	 hygiene	 interventions	 at	 slaughter	 ,	 the	 control	 of	48	
Salmonella	carriage	and	shedding	remains	a	challenge	in	most	countries	(Davies	et	al.,	2016).		49	
The	 persistent	 and	 frequently	 asymptomatic	 nature	 of	 porcine	 Salmonella	 infection	 and	 the	50	
organism’s	ability	to	colonize	other	animal	species,	such	as	rodents	and	wild	birds	on	farms,	and	to	51	
survive	 in	 the	 environment	 means	 that	 effective	 control	 generally	 requires	 multiple	 measures	52	
(Wales	 and	 Davies,	 2017).	 In	 summary,	 control	 measures	 against	 Salmonella	 infection	 can	 be	53	
divided	 into	 five	 broad	 interventions:	 biosecurity/SPF	 status,	 feed	management,	 acidification	 of	54	
feed	or	water,	manipulation	of	gut	microbiota,	and	vaccination	(Andres	and	Davies,	2015;	Wilhelm	55	
et	 al.,	 2017).	 Wilhelm	 et	 al.	 (2017)	 suggests	 that	 biosecurity	 and	 vaccination	 seem	 to	 be	 the	56	
intervention	 categories	 showing	 the	 greatest	 potential	 to	 minimise	 Salmonella	 on	 an	 infected	57	
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farm,	 and	 only	 culling	 of	 infected	 pigs	 can	 totallly	 eliminate	 infection,	 but	 in	 most	 countries	 a	58	




by	helping	 to	prevent	Salmonella	 colonizing	 the	gut	 and	 reducing	 the	 subsequent	 shedding	and	63	









(Wales	 and	 Davies,	 2017).	 Relatively	 few	 vaccination	 studies	 with	 Salmonella	 have	 been	73	
undertaken	under	field	conditions	on	pig	farms	and	most	of	these	have	been	conducted	with	small	74	
numbers	of	animals	(Schwarz	et	al.,	2011;	Arguello	et	al.,	2013;	De	Ridder	et	al.,	2014;	Ruggeri	et	75	
al.,	 2015;	 Davies	 et	 al.,	 2016).	 Several	 studies	 have	 evaluated	 	 live	 vaccines	 for	 Salmonella	76	
Choleraesuis,	a	serovar	that	is	particularly	pathogenic	to	both	pigs	and	some	humans	(Schwarz	et	77	
al.,	2011),	but	 is	now	rarely	reported	in	Europe	(EFSA,	2016;	Wales	and	Davies	et	al.,	2017).	The	78	
remaining	 studies	 have	 been	 carried	 out	 with	 an	 attenuated	 vaccine	 for	 S.	 Typhimurium	79	





Europe,	 representing	 8.3%,	 of	 69,663	 confirmed	 human	 cases	 in	 2015	 	 (EFSA,	 2016).	 These	83	
vaccination	studies	found	a	reduction	of	faecal	shedding	by	fattening	pigs	(Arguello	et	al.,	2013;	De	84	
Ridder	et	al.,	2014).	When	sows	plus	piglets	were	vaccinated,	a	consistent	reduction	in	shedding	85	
was	 observed,	 but	 results	were	more	 variable	 and	 lacked	 statistical	 significance	 (Ruggeri	 et	 al.,	86	
2015).	 Recently,	 Davies	 et	 al.	 (2016)	 examined	 the	 immunization	 of	 sows	 in	 three	 farms	 with	87	
follow-up	of	the	breeding	and	rearing	animals	for	up	to	two	years	after	the	initial	pre-vaccination	88	
visit.	 Although	 the	 study	 provided	 sustained	 reductions	 in	 Salmonella	 Typhimurium	 and	 mST-	89	
shedding	 among	 pigs	 up	 to	 slaughter	 age,	 it	 was	 based	 on	 an	 observational	 study	 under	 field	90	
conditions,	 which	 was	 uncontrolled.	 Longitudinal	 field	 studies	 examining	 natural	 infections	 are	91	











A	 total	 of	 35	 farms	were	 invited	 to	 participate	 in	 the	 study.	 Farms	were	 selected	based	on	 the	103	









Farms	were	 randomised	 into	 vaccinated	 (n=8)	 and	 non-vaccine	 (n=8).	 Farms	were	 followed	 for	111	
approximately	69	weeks	after	the	start	of	the	trial,	with	sampling	intervals	as	follow	(details	of	the	112	
study	 design	 are	 summarised	 in	 Table	 1).	 	 Briefly,	 sows	were	 vaccinated	with	 a	 live	 attenuated	113	
vaccine	 by	 subcutaneous	 injection	 (Salmoporc	 STM,	 IDT	 Biologika,	 Dessau-Rosslau,	 Germany).	114	
Vaccine	 was	 administered	 to	 pre-partum	 sows	 (6	 weeks	 and	 3	 weeks	 ante-partum)	 and	 one	115	
booster	dose	three	weeks	before	each	subsequent	farrowing.	The	first	dose	was	given	to	the	first	116	
batch	of	sows	in	week	1	and	the	second	dose	in	week	4.	The	piglets	(progeny)	from	the	first	batch	117	
of	 vaccine	 sows	were	estimated	 to	go	 to	 slaughter	during	week	33.	 The	 last	batch	of	 sows	was	118	
vaccinated	in	weeks	23	and	26	and	farrowed	in	week	29,	with	their	progeny	going	to	slaughter	in	119	












A	 minimum	 of	 sixty	 individual	 faeces	 samples	 were	 collected	 at	 each	 visit	 per	 epidemiological	130	
group	(gestation,	farrowing,	weaners,	growers,	finishers,	gilts,	dry	sows	and	boars)	where	possible	131	
given	 the	 number	 of	 animals	 present,	 providing	 a	 95%	 probability	 of	 detection	 assuming	 a	 5%	132	
prevalence	and	100%	sensitivity	of	detection.	Faeces	were	collected	in	sterile	stool	sample	tubes	133	
using	 an	 integral	 spoon.	 In	 addition,	 pooled	 pen	 faeces	 samples	 (one	 or	 two	 pools	 per	 pen	134	
according	 to	 the	 number	 of	 pigs	 in	 the	 pen,	 including	 pre-weaned	 piglet	 faeces	 in	 farrowing	135	
accommodation)	were	 taken,	 using	 a	 sterile	 gauze	 swab	 held	with	 a	 clean	 disposable	 glove	 for	136	
each	sample.	In	addition,	wildlife	and	environmental	samples	were	collected.	Solid	and	semi-solid	137	
material	was	 collected	 using	 sterile	 gauze	 swabs,	whilst	 surfaces	were	wiped	with	 gauze	 swabs	138	
that	 had	 been	 pre-autoclaved	 in	 buffered	 peptone	 water	 (BPW).	 Materials	 and	 areas	 sampled	139	
included:	rodent	faeces	and	(occasionally)	carcases;	wild	bird	faeces;	flies;	cleaned	and	empty	pens	140	





for	 Salmonella	 either	 immediately	 upon	 arrival	 (pooled	 faeces	 and	 swabs	 in	 BPW)	 or	 after	146	
overnight	 storage	at	4	 °C	 (individual	 faeces	samples),	using	a	modification	of	 the	 ISO	6579:2002	147	
(Annex	D)	method,	as	described	previously	(Martelli	et	al.,	2014).	Briefly,	all	pooled	faeces	samples	148	
(approximately	25	g)	and	swabs	were	pre-enriched	 in	225	ml	BPW	at	37oC	for	18	h	 followed	by	149	
enrichment	 in	 Modified	 Semi-Solid	 Rappaport-Vassiliadis	 medium	 (MRSV)	 for	 24h	 and	 48h	 at	150	
41.5oC	then	plating	on	Rambach	agar	which	was	incubated	for	24h	at	37oC.	Sub-samples	(2	g)	of	151	
individual	pig	faeces	samples,	and	samples	of	aseptically	dissected	rodent	carcass	 intestines	plus	152	





semi-quantitative	 enumeration	 procedure	 by	 creating	 a	 decimal	 dilution	 series	 in	 BPW	156	
immediately	before	pre-enrichment,	as	described	elsewhere	(Wales	et	al.,	2006).		157	
A	 selection	 (all	 isolates	 from	pooled	 samples	and	any	 individual	 sample	 that	was	cultured	semi-158	























to	 examine	 the	 association	 between	 time	 from	 the	 start	 of	 vaccination	 (represented	 by	 visit	180	
number,	with	the	first	visit	being	before	the	introduction	of	vaccination)	and	the	odds	of	a	sample	181	











A	 paired	 T-test	 was	 used	 to	 compare	 herd	 performance	 at	 the	 initial	 visit	 of	 the	 vaccination	193	
programme	 (visit	 1)	 and	at	 the	 final	 visit	 (visit	 4)	 for	 vaccine	and	non-vaccine	groups.	 Statistical	194	




From	35	 farms	 invited	 to	participate	 in	 the	study,	 six	 farms	were	not	eligible	as	no	ST/mST	was	199	
detected	from	pen	faecal	swab	sent	to	confirm	status.	A	further	seven	farms	were	rejected	due	to	200	
complex	multi-site	operations	which	would	have	 limited	the	ability	to	trace	the	vaccine	effect	 in	201	






farms,	 employed	 a	 two,	 three	 and	 four	 weeks	 batch	 system,	 respectively.	 In	 the	 non-vaccine	206	
group,	7	farms	used	a	weekly	batch	management	system	and	1	farm	employed	a	three	week	batch	207	
system.	The	mean	number	of	sow	and	gilts	per	herd	was	321	(range	from	150	to	550)	for	vaccine	208	
farms	 and	 406	 (range	 from	 150	 to	 750)	 for	 non-vaccine	 farms.	 Clinical	 problems	 (diarrhoea,	209	
septicaemia,	 ill-thrift	 and	 increased	 mortality)	 in	 weaned	 pigs,	 associated	 with	 Salmonella	210	





A	 total	 of	 22,246	 samples	 (9,747	 pooled	 faeces	 samples,	 10,905	 individual	 faeces	 samples	 and	216	
1,594	environmental	samples)	were	collected	between	April	2014	and	May	2016,	with	an	intense	217	
level	 of	 sampling	 per	 visit	 (mean	 of	 374	 samples	 collected	 in	 each	 visit),	 which	 increases	 the	218	
degree	of	confidence	in	the	results	.		Bacteriological	findings	from	faeces	samples	are	summarised	219	




62.2%	 for	 vaccine	 farms	 and	 from	 11.5%	 to	 67.0%	 for	 non-vaccine	 farms	 in	 pooled	 samples.	224	
Prevalence	 of	 ST/mST	was	 also	 high	 at	 visit	 1	 in	 both	 experimental	 groups	 (26.6%	 vs	 31.3%	 of	225	
pooled	 samples,	 17.8%	 vs	 21.7%	 of	 individual	 samples	 and	 30.1%	 vs	 46.3%	 of	 environmental	226	
samples,	for	vaccine	vs	non-vaccine	groups,	respectively).	At	the	second	and	third	visits,	following	227	
the	 start	of	 the	vaccination	programme,	 reduction	 in	prevalence	of	Salmonella	 and	ST/mST	was	228	
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not	 apparent	 in	 control	 farms.	 However,	 vaccine	 farms	 showed	 significantly	 (p=0.000)	 reduced	229	
Salmonella	 prevalence	 at	 the	 final	 visit	 (Table	 2).	 For	 pooled	 faecal	 samples,	 15.5%	 of	 vaccine	230	
farms’	 samples	were	 positive	 for	 	Salmonella,	while	 46.5%	of	 samples	 from	 control	 farms	were	231	
positive	 (p=0.005).	 For	 individual	 faeces,	 11.9%	 of	 the	 of	 vaccine	 farms	 samples	 were	 positive	232	
compared	with	35.5%	of	samples	from	the	non-vaccine	farms	(p=0.009).	Finally,	for	environmental	233	
samples,	 22.7%	of	 the	 samples	 from	 vaccinated	 farms	were	 Salmonella-positive	 compared	with	234	
48.9%	of	the	non-vaccine	farms	(p=0.035).	The	prevalence	of	Salmonella	and	ST/mST	was	reduced	235	
around	 20%	 and	 15%,	 respectively	 for	 all	 samples	 types.	 Vaccine	 farms	 showed	 significantly	236	
reduced	 ST/mST	 prevalence	 at	 the	 final	 visit	 (Table	 2).	 For	 pooled	 faecal	 samples,	 14.5%	 of	237	
samples	from	the	vaccine	farms	contained	Salmonella	compared	with	38.8%	for	the	non-vaccine	238	
farms	 (p=0.019).	 For	 individual	 faeces,	 11.6%	 of	 samples	 from	 vaccine	 farms	 were	 positive	 for	239	
Salmonella	 compared	 with	 29.7%	 of	 samples	 from	 non-vaccine	 farms	 (p=0.035).	 	 However,	 for	240	





of	 pigs	 for	 all	 the	 rearing	 stages.	 Weaners	 and	 finishers	 born	 from	 vaccinated	 sows	 showed	246	
significantly	 reduced	Salmonella	 sample	positivity	 (p=0.006	and	p=0.000,	 respectively.	 Figure	1).	247	












4,	 respectively).	 Similarly,	 the	 sample	 prevalence	 on	 the	 non-vaccine	 farms	 was	 not	 consistent	258	
over	time	on	all	units.	 In	one	farm,	a	marked	reduction	in	prevalence	of	Salmonella-positive	and	259	
ST/mSTs-positive	pooled	 and	 individual	 faeces	 samples	was	observed	 from	visit	 2	 (11.5%,	 3.2%,	260	
1.5%	and	2.1%	of	pooled	samples	for	visits	1,	2,	3	and	4,	respectively,	and	8.9%,	1.7%,	1.1%	and	261	
7.8%	of	individual	samples	for	visits	1,	2,	3	and	4,	respectively).	Nevertheless,	analyses	excluding	262	
data	 from	 inconsistent	 farms	showed	that	vaccinated	 farms	 (75%,	6/8)	experienced	a	significant	263	
reduction	in	Salmonella-positive	and	ST/mST-positive	samples	at	the	final	visit	of	around	50%	for	264	




Findings	 from	 the	 logistic	 regression	 analyses	 are	 summarised	 in	 table	 4.	 Examining	 the	269	
relationship	 between	 vaccine	 and	 non-vaccine	 farms,	 there	 was	 a	 significantly	 decreased	 odds	270	
ratio	 (OR	 =	 0.726,	 P<0.001)	 of	 Salmonella-positive	 and	 ST/mST-positive	 samples	 (OR	 =	 0.706,	271	
P<0.001)	 for	vaccine	 farms.	 	Examining	 the	 relationship	between	vaccine	and	non-vaccine	 farms	272	









increased	 odds	 (P<0.001)	 of	 Salmonella-positive	 and	 ST/mST-positive	 samples	 for	 all	 main	 pig	280	
group	types	compared	with	boars,		dry	sows	and	environmental	samples.			281	
	282	
The	 results	 of	 Salmonella	 enumeration	 in	 faecal	 samples	 across	 the	 trial	 are	 shown	 in	 Table	 5.		283	
Although	a	significant	reduction	of	Salmonella	and	ST/mST	prevalence	at	final	visit	was	observed,	284	

















Salmonella	 Typhimurium	 is	 able	 to	 reduce,	 in	 a	 substantial	 proportion	 of	 treated	 farms,	 both	302	
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faecal	 and	 environmental	 prevalence	 of	 Salmonella	 in	 farrow-to-finish	 pig	 herds,	 especially	 for	303	
serovars	S.	Typhimurium	and	its	monophasic	variants.	Nevertheless,	according	to	previous	studies,	304	
although	 a	 beneficial	 association	 between	 vaccination	 and	 Salmonella	 reduction	was	 observed,	305	
vaccination	 strategies	 alone	 are	 not	 sufficientto	 eliminate	 infection	 that	 is	 already	 present	 on	306	
breeding	pig	 farms	and	all	 vaccines	aimed	at	 intestinal	bacteria	 should	preferably	be	applied	 to	307	
uninfected	animals	on	a	preventative	basis	rather	than	in	the	face	in	infection	(Wales	et	al.,	2011;	308	
Soumpasis	et	al.,	2012).	The	persistent	and	frequently	asymptomatic	nature	of	porcine	Salmonella	309	
infection	 and	 the	 organism’s	 abilities	 to	 colonize	 other	 animal	 species	 and	 to	 survive,	 or	 even	310	
multiply,	 in	 the	 environment	 mean	 that	 effective	 control	 of	 subclinical	 Salmonella	 infection	311	
generally	requires	multiple	approaches	applied	simultaneously,	although	clinical	salmonellosis	can	312	
usually	be	markedly	improved	by	vaccination	alone,	as	demonstrated	in	the	current	study	(Wales	313	
and	 Davies,	 2017;	 Wilhelm	 et	 al.,	 2016).	 In	 conjunction	 with	 other	 control	 measures	 against	314	
Salmonella	 infection,	 vaccination	 may	 assist	 in	 the	 protection	 of	 animal	 health,	 reduction	 of	315	
antibiotic	 usage,	 enhancement	 of	 food	 safety	 as	 well	 as	 reduction	 of	 economic	 losses	 and	316	
environmental	contamination	associated	with	 faecal	waste,	 run-off	and	dust	 from	pig	 farms	and	317	
transmission	 of	 Salmonella	 to	 other	 food	 animal	 species,	 such	 as	 poultry,	 by	 wildlife	 vectors	318	





used	on	 the	 farms,	used	a	 large	numbers	of	animals	and	 focused	a	 	 controlled	and	 randomized	324	
study	 on	 farms	 with	 an	 existing	 Salmonella	 problem	 (Davies	 et	 al.,	 2016).	 Although	 direct	325	













progeny,	 was	 reduced	 and	 it	 was	 suggested	 that	 vaccination	 with	 an	 injectable	 vaccine	 for	337	
breeding	sows	could	be	an	easy-to-apply	and	economic	way	to	reduce	Salmonella	transmission	to	338	
progeny	 and	 enhance	 maternal	 immunity.	 	 Other	 studies	 have	 suggested	 that	 additional	339	
vaccination	of	sucking	piglets	and	weaners	would	provide	additional	benefits,	but	this	is	less	easy	340	
and	economic	to	carry	out	in	many	farming	systems	(Roesler	et	al.,	2006;	Andres	and	Davies,	2015;	341	
Ruggeri	 et	 al.,	 2015).	 Vaccination	 of	 sows	 only	would	 avoid	 the	 possibility	 of	 the	 vaccine	 strain	342	
being	present	in	the	lymphoid	tissue	of	slaughtered	progeny	(Wales	et	al.,	2011;	Wales	and	Davies,	343	
2017).	 Vaccinal	 protection	 of	 sows	 is	 particularly	 relevant	 in	 farrow-to-finish	 pig	 herds	 where	344	
breeders	 and	 finishing	 pigs	 are	 housed	 in	 the	 same	 environment	 and	 weaned	 pigs	 present	 a	345	
continuous	 source	 of	 environmental	 contamination	with	 ST	 or	mST.	 (Lurette	 et	 al.,	 2009).	 	 The	346	
carriage	 of	 Salmonella	 by	 piglets	 is	 readily	 demonstrated	 from	 the	 farrowing	 accommodation	347	
onwards	 (Wales	 et	 al.,	 2011).	 According	 to	 Kranker	 et	 al.	 (2003),	 Salmonella	 is	 predominant	 in	348	
weaners,	 growers,	 and	 finishers.	 Nevertheless,	 once	 all	 sows	 were	 vaccinated,	 a	 reduction	 in	349	





pig	herds	 is	also	consistent	with	enhanced	passive	 immunity,	clearance	of	 infection	and	reduced	353	
carriage	 of	 infection	 by	weaners,	 eventually	maturing	 into	 growers	 and	 finishers	 (Davies	 et	 al.,	354	
2016).	Although,	previous	findings	have	shown	that	pigs	born	from	vaccinated	sows	show	reduced	355	
Salmonella	 faecal	 shedding	 (Roesler	 et	 al.,	 2006;	 Matiasovic	 et	 al.,	 2013).	 The	 reduction	 in	356	
environmental	 contamination	 and	 re-cycling	 of	 infection	 is	 also	 important	 (Davies	 et	 al.	 2016).	357	
Collectively,	 our	 data	 suggest	 that	 maternal	 vaccination	 can	 significantly	 reduce	 carriage	 of		358	
Salmonella	in	the	progeny	of	vaccinated	pigs,	as	well	as	environmental	contamination.	359	
	360	
However,	 the	 Salmonella	 prevalence	 reduction	 observed	 in	 the	 vaccinated	 farms	 was	 not	361	
observed	in	all	herds,	and	this	 is	consistent	with	other	studies.	De	Ridder	et	al.	(2014),	using	the	362	
same	 vaccine,	 observed	 response	 variability	 in	 three	 farrow-to-finish	 pig	 herds.	 In	 our	 study,	 in	363	
two	herds,	vaccination	did	not	reduce	the	the	faecal	or	environmental	prevalence	of	Salmonella.	364	
Importantly,	 in	 these	 two	 farrow-to-finish	 pig	 herds	 acute	 outbreaks	 of	 salmonellosis	 occurred	365	
shortly	before	the	start	of	the	vaccination	program,	which	may	have	presented	an	overwhelming	366	
challenge	for	the	vaccine	within	the	timescale	of	the	study.	In	both	of	these	herds	staff	reported	a	367	
marked	 decline	 in	 clinical	 salmonellosis	 following	 the	 start	 of	 vaccination.	 It	 is	 known	 that	 live	368	
attenuated	 Salmonella	 Typhimurium	 vaccines	 can	 help	 prevent	 clinical	 salmonellosis,	 reducing	369	
tissue	colonization	and	faecal	shedding	(Roesler	et	al.,	2004;	Gradassi	et	al.,	2013).	In	one	of	these	370	
farrow-to-finish	 pig	 herds,	 peak	 prevalence	 occurred	 after	 the	 start	 of	 vaccination	 in	 the	 later	371	
stages	 of	 pig	 production.	 Specifically,	 prevalence	 increased	 from	 6.3%,	 7.5%	 and	 0%	 to	 46.9%,	372	
82.5%	 and	 36.7%,	 for	 weaners,	 growers	 and	 finishers,	 respectively.	 However,	 at	 the	 final	 visit,	373	
prevalence	level	for	weaners	was	0%,	but	growers	and	finishers	retained	high	prevalence	(87.8%	374	
and	44.7%,	respectively).	This	 is	 likely	to	represent	a	delayed	effect	of	the	vaccine	 in	the	face	of	375	
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very	 high	 levels	 of	 infection	 at	 the	 start	 of	 the	 study,	 but	 it	may	 also	 suggest	 other	 underlying	376	
precipitating	 factors	 relating	 to	 management	 of	 contamination	 in	 grower	 and	 finisher	377	
accommodation.	 	 In	the	other	farrow-to-finish	pig	herd	no	effect	after	vaccination	was	observed	378	
throughout	the	study.	 	Each	pig	farm	is	unique	in	terms	of	 location,	facilities,	management,	host	379	
susceptibility,	 and	 other	 influential	 factors	 (Andres	 and	 Davies,	 2015)’	 and	 there	 are	 several	380	
plausible	possible	explanations	for	the	variability	in	the	vaccinal	effect.	Under	field	conditions,	pigs	381	
are	 infected	 at	 different	 points	 in	 time,	 with	 a	 herd-dependent	 and	 even	 batch-dependent	382	
variability	 in	both	 infection	pressure	and	host	 response	 (Beloeil	 et	 al.,	 2003;	 Lo	 Fo	Wong	et	 al.,	383	
2004;	Rostagno	et	al.,	2012).	Similarly,	the	presence	of	herd-specific	S.	enterica	strains	might	have	384	
affected	the	impact	of	vaccination	(Van	Parys	et	al.,	2013).	There	may	also	have	been	interactions,	385	




It	 should	 be	 noted	 that	 this	 farm	 had	 the	 second	 lowest	 prevalence	 level	 of	 all	 farms	 at	 the	390	
beginning	of	the	study.	A	plausible	explanation	may	be	that	existing	farm	hygiene	and	biosecurity	391	
controls	 were	 being	 better	 implemented	 and	 maintained	 ot	 that	 the	 management	 systems	 in	392	
place	 involved	 exposure	 to	 infection	 at	 times	 that	 could	maximise	 the	 development	 of	 natural	393	
herd	 imunity	 (Knetter	 et	 al.,	 2015)	 	 	 (Davies	 et	 al.,	 2016),	 or	 some	 farm-resident	 strains	 may	394	
theoretically	 lose	virulence	over	time	(Hayden	et.	al,	2016)	 .	Nonetheless,	analysis	excludes	data	395	
from	 these	 farrow-to-finish	 pig	 herds	 suggests	 an	underlying	 effect	 of	 vaccination	 that	 is	 in	 the	396	
same	 way	 than	 that	 shown	 by	 the	 complete	 dataset	 (about	 50%).	 The	 overall	 study	 findings	397	
demonstrate	 that	 it	 is	 reasonable	 to	 postulate	 that	 maternal	 vaccination	 strategy	 at	 least	398	






and	 environmental	 sample,	 present	 the	 similar	 reductions	 in	Salmonella-positivity,	 even	 though	403	
pooled	pen	faecal	samples	e	are	highly	sensitive	sample	types	and	the	culture	method	used		can	404	
identify	small	numbers	of	organisms	(Fedorka-Cray	et	al.,	2000)	and	a	low	within-group	Salmonella	405	










Although	23	 serovars	were	 isolated,	many	of	 these	 serovars	were	 likely	 to	have	been	 transient.	416	
Shedding	was	generally	low	and	none	of	the	other	serovars	found	have	a	similarly	high	pathogenic	417	
importance	 for	 humans	 as	 ST/mST.	 No	 significant	 control	 of	 non-ST/mST	 Salmonella	 serovars	418	
following	 vaccination	 was	 observed,	 probably	 due	 by	 the	 limited	 cross-protection	 against	 non-419	
target	 serovars	 provided	 by	 current	 vaccines	 (Wallis	 2001;	 Foss	 et	 al.,	 2013;	 Foss	 et	 al.,	 2013;	420	
Bearson	 et	 al.,	 2016),	 despite	 the	 fact	 that	 it	 has	 been	 reported	 that	 vaccination	 against	 S.	421	
Choleraesuis	can	cross-protect	pigs	against	S.	Typhimurium	(Nnalue	and	Stocker	1987;	Maes	et	al.,	422	
2001).	 The	 significant	 reduction	 in	 isolation	 of	 ‘all	 salmonellas’	 over	 time	 reflects	 the	 high	423	
prevalence	 of	 S.	 Typhimurium	 and	 monophasic	 variants	 	 isolates	 in	 UK	 pigs	 and	 in	 this	 study	424	
19	
	
(Davies	 et	 al.,	 2016).	 	 The	most	 important	 finding	 is	 that	 serovars	 that	 pose	 the	 highest	 risk	 to	425	




reducing	 salmonellosis	 and	 the	 need	 to	 medicate	 pigs	 at	 weaning,	 improving	 feed	 conversion	430	
efficiency	 and	 daily	 live	weight	 gain	 (Andres	 and	 Davies,	 et	 al.,	 2015).	 In	 this	 context,	 previous	431	
studies	have	demonstrated	average	daily	 gain	benefits	 as	 a	 result	of	 vaccination	of	pre-weaned	432	
piglets	(Farzan	and	Friendship,	2010;	De	Ridder	et	al.,	2014).	In	contrast,	Husa	et	al.	(2009),	in	an	433	
experimental	 trial,	 reported	 that	 the	 growth	 rate	 was	 lower	 in	 piglets	 vaccinated	 with	 a	434	
commercial	 S.	 Choleraesuis/S.Typhimurium	 live	 vaccine	 than	 in	 unvaccinated	 piglets	 due	 to	435	
adverse	reactions	after	vaccination,	but	the	vaccine	was	protective	against	subsequent	challenge.		436	






infected	 pigs	 and	 suggested	 that	 feed	 conversion	 efficiency	may	 have	 been	 improved,	 but	 it	 is	443	
likely	 that	 Salmonella	 infection	 depressed	 the	 appetite	 of	 the	 non-vaccinated	 study	 pigs	 ,	 but	444	
significant	improvements	in	growth	parameters	were	not	observed	in	the	current	study.	445	
	446	





and	 environmental	 prevalence	 of	 Salmonella,	 especially	 for	 serovars	 S.	 Typhimurium	 and	 its	450	
monophasic	 variants.	Salmonella	 vaccines	 therefore	 have	 the	 potential	 to	 reduce	 prevalence	 of	451	
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Table	 1.	 Example	 schedule	 for	 a	 vaccination	 program	 on	 a	 weekly-farrowing	 system	 with	 23	592	
batches	of	pigs.	593	
	594	
595	 Week Event Sampling 
0 Initial  sampling  visit 




 vaccination of first batch of sows (6 weeks ante-partum)  
4 2
nd
 vaccination of first batch of sows (3 weeks ante-partum)  
7 First batch of sows farrow  
21 1st Mid study sampling 
Full set of animal samples 
Environmental samples 
23 1st vaccination of last batch of sows  
25 Pre-2
nd
 farrowing booster to 1
st
 batch of sows  
26 2
nd
 vaccination of last batch of sows  
28 Second farrowing, 1
st
 batch of sows  
29 First farrowing, last batch of sows  
33 Pigs from first farrowing of 1st batch of sows go to slaughter  
46 Pre-3rd farrowing booster to 1st batch of sows  
47 Booster vaccination of last batch of sows (3 weeks prior to 2nd farrowing)  
49 Third farrowing, 1
st
 batch of sows  
50 Second farrowing of last batch of sows  
54 Pigs from 2nd farrowing of first batch of sows go to slaughter  
55 
2nd Mid study sampling (all finishers on farm from vaccinated sows) 
Pigs from 1st farrowing of last batch of sows go to slaughter 
Full set of animal samples	
Environmental samples 
68 Booster vaccination of last batch of sows (3 weeks prior to 3rd farrowing)  
69 Final sampling visit 

















N	 Vaccine	 N	 Control	 SE	 P	value	 N	 Vaccine	 N	 Control	 SE	 P	value	 N	 Vaccine	 N	 Control	 SE	 P	value	
1	
(0)	
8	 1,297	 30.8	 1,169	 36.2	 6.94	 0.591	 1,430	 19.1	 1,062	 21.9	 5.47	 0.722	 238	 34.6	 160	 53.0	 8.37	 0.143	
2	
(161-182)	
8	 1,268	 28.2	 1,240	 32.0	 7.64	 0.731	 1,429	 20.0	 1,382	 26.9	 5.81	 0.415	 201	 29.2	 159	 47.4	 8.82	 0.162	
3	
(308-402)	 8	 1,279	 26.1	 1,178	 31.4	 6.87	 0.588	 1,394	 20.6	 1,360	 26.8	 5.24	 0.412	 188	 31.3	 228	 40.6	 9.26	 0.489	
4	




	 6.64	 0.041	 1,423	 13.4
b






N	 Vaccine	 N	 Control	 SE	 P	value	 N	 Vaccine	 N	 Control	 SE	 P	value	 N	 Vaccine	 N	 Control	 SE	 P	value	
1	
(0)	
8	 1,297	 26.6	 1,169	 31.3	 6.69	 0.624	 1,430	 17.8	 1,062	 21.7	 5.17	 0.603	 238	 30.1	 160	 46.3	 9.20	 0.234	
2	
(161-182)	
8	 1,268	 26.4	 1,240	 26.0	 7.70	 0.962	 1,429	 19.5	 1,382	 23.2	 5.55	 0.639	 201	 28.7	 159	 40.8	 9.39	 0.378	
3	
(308-402)	
8	 1,279	 24.2	 1,178	 27.8	 7.09	 0.727	 1,394	 18.7	 1,360	 23.8	 5.13	 0.498	 188	 27.2	 228	 36.6	 9.22	 0.480	
4	
(514-569)	














N	 Vaccine	 SE	 N	 Control	 SE	 P	value	 N	 Vaccine	 SE	 N	 Control	 SE	 P	value	 N	 Vaccine	 SE	 N	 Control	 SE	 P	value	
1	
(0)	
955	 36.2	 7.34	 990	 40.2	 6.80	 0.703	 955	 22.7	 6.40	 883	 23.7	 5.93	 0.907	 185	 44.7	 9.02	 148	 52.2	 8.35	 0.551	
2	
(161-182)	
934	 30.1	 8.28	 1062	 36.2	 8.17	 0.622	 934	 21.8	 6.70	 1,202	 30.4	 6.20	 0.368	 163	 31.9	 9.67	 147	 53.3	 8.95	 0.133	
3	




	 6.41	 812	 46.5






N	 Vaccine	 SE	 N	 Control	 SE	 P	value	 N	 Vaccine	
SE	 N	 Control	 SE	 P	value	 N	 Vaccine	 SE	 N	 Control	 SE	 P	value	
1	
(0)	
955	 30.8	 7.49	 990	 34.6	 6.94	 0.72	 955	 21.0	 6.05	 883	 23.6	 5.60	 0.766	 185	 39.7	 10.39	 148	 44.6	 9.62	 0.735	
2	
(161-182)	
934	 28.0	 9.27	 1062	 29.2	 8.58	 0.922	 934	 21.2	 6.55	 1,202	 26.3	 6.07	 0.580	 163	 31.2	 10.96	 147	 45.5	 10.15	 0.361	
3	




	 6.50	 812	 38.8
a
	 6.02	 0.019	 974	 11.6
b
	 5.54	 1,246	 29.7
a







	 	 Salmonella-positive	 ST/mST-positivea	
	 	 Odds	ratio	 p-value	 Odds	ratio	 p-value	
Farm	type	 Non-vaccinated	 Ref.	 	 	 	
	 Vaccine	 0.726	 <0.001	 0.706	 <0.001	
Visit	x	Farm	type	 1	x		Farm	type	 Ref.	 	 	 	
	 2	x		Farm	type	 1.070	 0.492	 1.311	 0.008	
	 3	x		Farm	type	 1.028	 0.775	 1.043	 0.667	
	 4	x		Farm	type	 0.512	 <0.001	 0.613	 <0.001	
Sample	type	 Individual	 Ref.	 	 	 	
	 Pooled	 2.697	 <0.001	 2.558	 <0.001	
Season	 Winter	 Ref.	 	 	 	
	 Spring	 1.090	 0.070	 1.119	 0.025	
	 Summer	 1.214	 0.004	 1.198	 0.013	
	 Autumn	 1.069	 0.268	 1.130	 0.047	
Pig	type	 Gestation	 Ref.	 	 	 	
	 Boars	 1.496	 0.564	 1.842	 0.381	
	 Farrowing	 0.559	 <0.001	 0.610	 <0.001	
	 Weaners	 6.292	 <0.001	 6.995	 <0.001	
	 Growers	 5.349	 <0.001	 6.119	 <0.001	
	 Finishers	 3.261	 <0.001	 3.732	 <0.001	
	 Gilts	 1.733	 <0.001	 2.069	 <0.001	
	 Environmental	 4.252	 <0.001	 4.987	 <0.001	
	 Dry	sows	 2.269	 <0.001	 3.061	 <0.001	
	 Mixed	 3.252	 <0.001	 3.640	 <0.001	
Visit	 1	 Ref.	 	 	 	
	 2	 0.783	 0.001	 0.721	 <0.001	
	 3	 0.890	 0.086	 0.934	 0.326	










<1	 1-10	 1-102	 102-103	 103-104	 104-105	
Vaccine	
1	 188	 60.1	 16.5	 11.2	 9.6	 1.6	 1.1	
2	 221	 57.0	 23.1	 11.8	 6.8	 0.9	 0.5	
3	 242	 54.1	 24.4	 15.3	 2.9	 2.1	 1.2	
4	 274	 60.9	 15.3	 9.5	 7.7	 4.0	 2.6	
Non-vaccinated	
1	 163	 59.5	 20.0	 13.5	 5.5	 1.2	 0.0	
2	 251	 40.2	 31.1	 14.3	 9.6	 3.2	 1.6	
3	 247	 53.8	 19.0	 15.4	 10.9	 0.4	 0.4	








































N	 Mean	 N	 Mean	
Piglets	born	 1	 8	 13.4	 7	 13.0	4	 8	 14.3	 5	 13.1	
Piglets	weaned	 1	 8	 11.4	 7	 11.4	4	 8	 12.0	 5	 11.3	
Pigs	sold	per	sow	per	year	 1	 8	 26.3	 7	 23.5	4	 7	 26.0	 5	 23.9	
Slaughter	live	weight	(Kg)	 1	 7	 117.0	 6	 101.7	4	 7	 115.0	 5	 106.4	
Litters	per	sow	 1	 8	 2.4	 7	 2.3	4	 8	 2.4	 5	 2.3	
Sow	mortality	(%)	 1	 8	 6.0	 6	 2.9	4	 7	 11.0	 2	 3.0	
Replacement	sows	(%)	 1	 8	 48.0	 7	 45.6	4	 8	 72.0	 4	 58.5	
Sow	parity	maximum	 1	 7	 7.0	 6	 6.3	4	 7	 7.0	 3	 5.3	
Pre-weaning	mortality	(%)	 1	 8	 16.9	 7	 11.5	4	 8	 17.1	 5	 13.8	
Weaning	age	(days)	 1	 7	 27.0	 4	 25.7	4	 7	 27.0	 5	 25.3	
Post-weaning	mortality	weaners	(%)	 1	 8	 5.5	 6	 3.5	4	 7	 5.7	 3	 4.8	
Post-weaning	mortality	growers	(%)	 1	 8	 5.5	 6	 2.7	4	 7	 5.7	 3	 4.4	
Post-weaning	mortality	finishers	(%)	 1	 8	 5.5	 6	 3.0	4	 7	 5.7	 4	 4.5	
Daily	live	weight	gain*	(g)	 1	 8	 830.0	 5	 729.8	4	 7	 938.0	 4	 685.0	









sows	at	weaners,	 growers	and	 finishers	 rearing	 states.	Data	are	expressed	as	means	±	 standard	661	
error.	a,b		Grouped	bar	with	uncommon	letters	are	different	(P<0.05).	662	
		663	
	664	
	665	
	666	
	667	
	668	
	669	
	670	
	671	
